Larson Financial Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Larson Financial Group's NKTR Position: Q3 2026 in Review
Larson Financial Group opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 28 shares worth $1.7K. The stake represents ﹤0.01% of the portfolio and ranks #3263 among its holdings.
243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Larson Financial Group held 28 shares of Nektar Therapeutics worth $1.7K as of Q3 2026.
- Nektar Therapeutics was a new Larson Financial Group position in Q3 2026.
- Nektar Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3263 holding.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.